Seeing Is Believing

Currently out of the existing stock ratings of Edward Tenthoff, 663 are a BUY (90.45%), 60 are a HOLD (8.19%), 10 are a SELL (1.36%).
Analyst Edward Tenthoff, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 48.06% that have a potential upside of 52.09% achieved within 289 days.
Edward Tenthoff’s has documented 1,471 price targets and ratings displayed on 81 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on ARWR, Arrowhead Pharmaceuticals at 17-Dec-2025.
Analyst best performing recommendations are on MIST (MILESTONE PHARMACEUTICALS).
The best stock recommendation documented was for MIST (MILESTONE PHARMACEUTICALS) at 3/23/2020. The price target of $3 was fulfilled within 1 day with a profit of $11 (78.57%) receiving and performance score of 785.71.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 28-Oct-2022
$12
$-15.6 (-56.52%)
2 years 1 months 25 days ago
(13-Nov-2023)
2/2 (100%)
$1.82 (17.88%)
14
Buy
Since 25-Jul-2023
$23
$-4.6 (-16.67%)
$22.5
2 years 3 months 27 days ago
(11-Sep-2023)
2/2 (100%)
$8.95 (63.70%)
141
Hold
Since 03-Jun-2022
$25
$-2.6 (-9.42%)
2 years 10 months 4 days ago
(03-Mar-2023)
1/3 (33.33%)
$15.15 (153.81%)
325
Hold
Since 27-Oct-2022
$25
3 years 2 months 11 days ago
(27-Oct-2022)
1/4 (25%)
$6.75 (36.99%)
151
Buy
$11
3 years 7 months 5 days ago
(03-Jun-2022)
2/2 (100%)
$3.33 (40.64%)
1025
Which stock is Edward Tenthoff is most bullish on?
Which stock is Edward Tenthoff is most reserved on?
What Year was the first public recommendation made by Edward Tenthoff?